P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL

Detalles Bibliográficos
Autores principales: Koviazin, A., Filatova, L., Zyuzgin, I., Artemyeva, A., Motalkina, M., Chudinovskikh, Y., Volchenkov, S., Poliatskin, I., Dobrovolskaya, E., Shalaev, S., Ishmatova, I., Zverkova, A., Burda, D., Elkhova, S., Semiglazova, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430834/
http://dx.doi.org/10.1097/01.HS9.0000848264.70663.5a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430834/
http://dx.doi.org/10.1097/01.HS9.0000848264.70663.5a

Ejemplares similares